HROW as of Nov 2 · 04:05 ET
HROWNasdaqPharmaceutical Preparations

Harrow, Inc. · Brief

Next report

7 days

Nov 9 · after closeest.Q3 FY26

Expected move

Inputs

Implied vs realized

8 reportsHistory
3 of 8≥ implied
avg implied
±14.6%
avg realized
±11.3%
Mar 27 '25±14.1%▼−5.96%×0.42
May 8 '25±18.6%▲+3.43%×0.18
Aug 11 '25±16.7%▲+3.23%×0.19
Q3 FY25±17.2%▲+13.47%×0.78
Feb 2 '26±9.2%▲+9.67%×1.05
Q1 FY26±15.1%▼−27.96%×1.85
May 11 '26±12.6%▼−23.69%×1.88
Q2 FY26±13.4%▼−3.14%×0.23
quarterimplied−30%0+30%realized×
Q2 FY26±13.4%▼−3.14%×0.23
May '26±12.6%▼−23.69%×1.88
Q1 FY26±15.1%▼−27.96%×1.85
Feb '26±9.2%▲+9.67%×1.05
Q3 FY25±17.2%▲+13.47%×0.78
Aug '25±16.7%▲+3.23%×0.19
2 older reports
May '25±18.6%▲+3.43%×0.18
Mar '25±14.1%▼−5.96%×0.42
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 9 report · est.

Bull2 of 3

223managers reporting a position in the latest quarterly filings13F · Jun 30 '26
+0.66%change in shares held by the ten largest reporting managers over the latest quarter13F · Jun 30 '26

Bear2 of 3

24managers whose positions together make up four fifths of reported value13F · Jun 30 '26
4 of 19of the largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26
AI captions · Sep 28 '26once per report · top 2 per case

Linked exposure

HROW report session

No linked exposure.

Latest changes

30 daysAll changes
Oct 26impliedImplied move: ±15.2% into Nov 9 earnings (Oct 26 close).Source
Oct 58-KMaterial agreement: Amended and Restated Asset Purchase Agreement with Viatris Inc.Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.